in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Cedarburg Seeks to Bounce Back with New Offering
11:40 AM MDT | July 25, 2007 | Alex Scott
Privately owned process development and active pharma ingredient (API) manufacturer Cedarburg Pharmaceuticals (Grafton, WI) says it has been struggling in the highly competitive generic pharmaceuticals market and so is switching its focus toward the ethical pharma market, including projects for ‘virtual’ pharma and major pharma. The company tells CW that it recently raised $3.5 million from private investors and a debt offering to bolster this new direction. The funding will primarily be used to expand the firm’s capabilities in the virtual...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee